Old Breast Cancer Treatments May Lead to Lung Cancer

Publication
Article
OncologyONCOLOGY Vol 9 No 4
Volume 9
Issue 4

If a woman smoked, contracted breast cancer, and was treated with radiation before 1980, her risk of lung cancer has been dramatically increased. Even if she did not smoke, her chances for lung

If a woman smoked, contracted breast cancer, and was treated withradiation before 1980, her risk of lung cancer has been dramaticallyincreased. Even if she did not smoke, her chances for lung cancerrose. These are the findings of a preliminary study conductedat the Columbia University College of Physicians & Surgeonsby Alfred I. Neugut, MD, PhD, an associate professor of clinicalmedicine and public health.

The study compared 89 breast cancer patients diagnosed with lungcancer since 1986 with more than 1,000 breast cancer patientsdiagnosed with nonsmoking, nonradiation related malignancies duringthe same period. Neugut showed that the smokers with breast cancerhad more than 30 times the risk of lung cancer compared with thosewho didn't smoke and had not received radiation.

"This is the first time that a combined risk for lung cancerfrom cigarette smoking and therapeutic radiation has been shown,"Neugut said. "That the excess lung cancer was on the sameside as the breast that was irradiated strongly indicates a causalrelationship and not a statistical fluke."

Now that radiation therapy has improved, delivering narrower,more focused and contoured beams, the associated risks may beconsiderably lower, Neugut notes. In the widely used radiationtechniques following lumpectomy, the beam is directed toward thebreast tissue, away from the chest wall and lung.

Neugut's study confirms his earlier findings which showed a doublingof lung cancer risk following breast cancer radiation therapy.The current study extends these findings to stress the higherrisk of lung cancer for smokers.

Still, he says, the results must be considered preliminary becausethere were some gaps in the data and the numbers were small. "However,the magnitude of the risk and the consistency of the findingsboth within the study and with our prior knowledge of the effectof radiation on the lung support the validity of the findings,"Neugut said.

To verify these results, he is planning a larger scale study.Additionally, Neugut and his colleagues are exploring the combinedeffects of radiation therapy and smoking on patients with Hodgkin'sdisease and lung cancer to see if they find a similar effect.

Recent Videos
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Thinking about how to sequence additional agents following targeted therapy may be a key consideration in the future of lung cancer care.
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
Advancements in antibody drug conjugates, bispecific therapies, and other targeted agents may hold promise in lung cancer management.
Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.
Thomas Marron, MD, PhD, presented a session on clinical data that established standards of care for stage II and III lung cancer treatment at CFS 2025.
Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer. Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer.
Related Content